Publications

(Updated on 1/12/2021)

Kim J. "Identification of metastatic breast cancer-specific biological pathways and novel prognostic biomarkers for breast cancer" World Journal of Surgical Oncology. Under review.

Kim J and Ma L. "Capturing Endogenous Long Noncoding RNAs and Their Binding Partners Using Chromatin Isolation by RNA Purification (ChIRP)" Methods in Molecular Biology. In press.

Kim HJ and Kim J. "OTUD6A is an AURORA Kinase A-specific deubiquitinase" International Journal of Molecular Sciences (2021) 22(4):1936.

Yang J*, Lee SJ*, Kwon Y, Ma L, Kim J. “Tumor suppressive function of Matrin 3 in the basal-like breast cancer” Biological Research (2020) 53(1):42. (*Co-first authors)

Gwak J, Jeong H, Lee K, Shin JY, Sim T, Kim J, Ju BG. “SFMBT2-mediated infiltration of preadipocytes and TAMs in prostate cancer” Cancers (2020) 12(9):E2718.

Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, Tyagi S, Ma L, Westbrook TF, Steinberg GR, Nakada D, Stockwell BR, Gan B. “Energy-stress-mediated AMPK activation inhibits ferroptosis” Nature Cell Biology (2020) 22(2):225-234.

Nguyen TM, Kabotyanski EB, Reineke LC, Shao J, Xiong F, Lee JH, Dubrulle J, Johnson H, Stossi F, Tsoi PS, Choi KJ, Ellis AG, Zhao N, Cao J, Adewunmi O, Ferreon JC, Ferreon ACM, Neilson JR, Mancini MA, Chen X, Kim J, Ma L, Li W, Rosen JM. “The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis” Nucleic Acids Research (2020) 48(5):2621-2642.

Xiao Z, Chang L, Kim J, Zhang P, Hang Q, Yap S, Guo Y, Zhou Z, Zeng L, Hu X, Siverly A, Sun Y, Ma L. “USP37 is a SNAI1 deubiquitinase” American Journal of Cancer Research (2019) 9(12):2749-2759.

Kim J. “Long noncoding RNA MALAT1 and cancer metastasis” Biotarget (2019) 3(5).

Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, Lee H, Zhou Z, Gan B, Nakagawa S, Ellis MJ, Liang H, Hung MC, You MJ, Sun Y, Ma L. “Long non-coding RNA MALAT1 suppresses breast cancer metastasis” Nature Genetics (2018) 50(12):1705-1715.

Kim J, Naini F, Sun Y, Ma L. “Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin” American Journal of Cancer Research (2018) 8(9):1823-1836.

Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton BN, Chang L, Liu N, Zeng L, Wang W, Wang Y, Zhang P, Hu X, Su X, Liang H, Sun Y, Ma L. “SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity” Nature Communications (2018) 9(1):2269.

Zhang P, Xiao Z, Wang S, Zhang M, Wei Y, Hang Q, Kim J, Yao F, Rodriguez-Aguayo C, Ton BN, Lee M, Wang Y, Zhou Z, Zeng L, Hu X, Lawhon SE, Siverly AN, Su X, Li J, Xie X, Cheng X, Liu LC, Chang HW, Chiang SF, Lopez-Berestein G, Sood AK, Chen J, You MJ, Sun SC, Liang H, Huang Y, Yang X, Sun D, Sun Y, Hung MC, Ma L. “ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.” Cell Reports (2018) 23(3):823-837.

Kim J, Yao F, Xiao Z, Sun Y, Ma L. “MicroRNAs and metastasis: small RNAs play big roles” Cancer and Metastasis Reviews (2017) 37(1):5-15. (Invited review)

Zhou Z, Zhang P, Hu X, Kim J, Yao F, Xiao Z, Zeng L, Chang L, Sun Y, Ma L. “USP51 promotes deubiquitination and stabilization of ZEB1” American Journal of Cancer Research (2017) 7(10):2020-2031.

Kim J, Siverly AN, Chen D, Wang M, Yuan Y, Wang Y, Lee H, Zhang  J, Muller WJ, Liang H, Gan Boyi, Yang X, Sun Y, You MJ & Ma L. “Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways” Cancer Research (2016) 76(21):6424-6435.

Lee H, Dai F, Zhuang L, Xiao ZD, Kim J, Zhang Y, Ma L, You MJ, Wang Z, Gan B. “BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21” Oncotarget (2016) 7(15):19134-46.

Li CW, Xia W, Lim SO, Hsu JL, Huo L, Wu Y, Li LY, Lai CC, Chang SS, Hsu YH, Sun HL, Kim J, Yamaguchi H, Lee DF, Wang H, Wang Y, Chou CK, Hsu JM, Lai YJ, LaBaff AM, Ding Q, Ko HW, Tsai FJ, Tsai CH, Hortobagyi GN and Hung MC. “AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation” Cancer Research (2016) 76(6):1451-62.

Kim J, Roh M, Irina D, Algarroba GN, Eltoum IE and Abdulkadir SA. “A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53” Oncogene (2012) 31(3):322-32.

Kim J, Roh M and Abdulkadir SA. “Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity” BMC Cancer (2010) 10:248. A Highly Accessed Article.

Wang J, Kim J, Roh M, Franco OE, Hayward SW, Wills ML and Abdulkadir SA. “Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma” Oncogene (2010) 29(17):2477-87.

Kim J, Eltoum IE, Roh M, Wang J and Abdulkadir SA. “Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer” PLoS Genetics (2009) 5(7):e1000542.

Roh M, Kim J, Song C, Wills M and Abdulkadir SA. “Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues” Genesis (2006) 44(10):447-53.

Roh M, Song C, Kim J and Abdulkadir SA. “Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1” The Journal of Biological Chemistry (2005) 280(49):40568-40577.

Abdulkadir SA and Kim J. “Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility” Future Oncology (2005) 1(3):351-360. (Invited review)